
invasive treatments, these Ô¨Ågures are likely underestimates of
the current costs for PAD care in the United States.
Evidence of underlying PAD may be present in the
absence of symptoms. For the purpose of this document,
this is referred to as asymptomatic disease. Symptomatic
PAD may present as IC, or with signs or symptoms consistent
with limb-threatening ischemia, often referred to as critical
limb ischemia (CLI). In this guidelines document,